The Enterprise Value as of December 2024 (TTM) for Blueprint Medicines Corporation (BPMC) is 6.12B

According to Blueprint Medicines Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 6.12B. This represents a change of -7.74% compared to the average of 6.63B of the last 4 quarters.

Blueprint Medicines Corporation (BPMC) Historical Enterprise Value (quarterly & annually)

How has BPMC Enterprise Value performed in the past?

The mean historical Enterprise Value of Blueprint Medicines Corporation over the last ten years is 3.01B. The current 6.12B Enterprise Value has changed 20.25% with respect to the historical average. Over the past ten years (40 quarters), BPMC's Enterprise Value was at its highest in in the June 2024 quarter at 7.55B. The Enterprise Value was at its lowest in in the June 2015 quarter at 271.71M.

Blueprint Medicines Corporation (BPMC) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Blueprint Medicines Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Blueprint Medicines Corporation (BPMC) Average Enterprise Value

How has BPMC Enterprise Value performed in the past?

The current Enterprise Value of Blueprint Medicines Corporation (BPMC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Blueprint Medicines Corporation (BPMC) Enterprise Value vs. Peers

How is BPMC’s Enterprise Value compared to its peers?

Blueprint Medicines Corporation’s Enterprise Value is greater than Terns Pharmaceuticals, Inc. (234.86M), greater than Amylyx Pharmaceuticals, Inc. (209.72M), greater than Acumen Pharmaceuticals, Inc. (103.15M), greater than Inozyme Pharma, Inc. (215.58M), greater than X4 Pharmaceuticals, Inc. (79.21M), greater than PTC Therapeutics, Inc. (3.39B), greater than Krystal Biotech, Inc. (4.25B), greater than Intercept Pharmaceuticals, Inc. (915.81M), less than Madrigal Pharmaceuticals, Inc. (6.67B), greater than Day One Biopharmaceuticals, Inc. (859.59M), greater than Mereo BioPharma Group plc (445.16M), greater than IVERIC bio, Inc. (5.13B), less than Karuna Therapeutics, Inc. (12.43B),

Build a custom stock screener for Blueprint Medicines Corporation (BPMC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Blueprint Medicines Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Blueprint Medicines Corporation (BPMC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Blueprint Medicines Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.